Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1038 participants.
Also called NCT04057300
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,038 participants
- Registry
-
NCT04057300
-
- Other papers using this trial's data
- Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes trial (TC4): a Bayesian pragmatic cluster randomized controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT04057300. Randomized; no masking; primary purpose treatment. Start 2018-10-01 (actual); primary completion 2022-04-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
- Acronym
- TC4
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Ticagrelor 90mg
- Intervention (Drug)
- Clopidogrel 75mg
- Intervention (Drug)
- acetylsalicylic acid (ASA) 81mg
- Lead sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Collaborator
- Canadian Institutes of Health Research (CIHR)
Record details
- Record id
cardio:ct-nct04057300- Content hash
f9892c990ac21a4da50829875598a158cbb5ce039e909dbeab5c5ba140b67d47